MKL 697.04 Markel Corp $MKL Hit a 52 week high of 700.00

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
MKL 697.04 Markel Corp $MKL Hit a 52 week high of 700.00 Closing the day 11/06/14 at 697.04 +7.99 +1.16% With a day low of 684.81 and a total volume of 40,572.

MKL Recent Posts: http://investorshangout.com/Markel-Corp-MKL-51820/

MKL Markel Corp Recent Headline News

Markel misses 3Q profit forecasts
Automated Insights - Thu Nov 06, 4:04AM CST
GLEN ALLEN, Va. (AP) _ Markel Corp. (MKL) on Thursday reported third-quarter earnings of $75.8 million.
MKL: 697.04 (+7.99)

Markel Reports Third Quarter And Nine-Months Results
PR Newswire - Wed Nov 05, 3:37PM CST
Markel Corporation (NYSE: MKL) reported book value per common share outstanding of $514.06 at September 30, 2014, up 8% from $477.16 at December 31, 2013. Comprehensive income to shareholders was $36.5 million for the third quarter of 2014 compared to $144.4 million for the same period of 2013. Comprehensive income to shareholders was $517.4 million for the nine months ended September 30, 2014 compared to $253.0 million for the same period of 2013. The combined ratio was 97% for the third quarter of 2014 compared to 96% for the third quarter of 2013. The combined ratio was 97% for both the nine months ended September 30, 2014 and 2013. Diluted net income per share was $5.30 for the quarter ended September 30, 2014 compared to $4.67 for the third quarter of 2013. Diluted net income per share was $14.21 for the nine months ended September 30, 2014 compared to $15.33 for the same period of 2013.
MKL: 697.04 (+7.99)

Markel Announces Conference Call Date And Time
PR Newswire - Thu Oct 30, 3:30PM CDT
Markel Corporation (NYSE: MKL) announced today it will hold a conference call on Thursday, November 6, 2014 beginning at 10:30 am (Eastern Standard Time) to discuss quarterly results and business developments.
MKL: 697.04 (+7.99)

Markel Hits 52-Week High on Possibility of Strong Q3 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 12:37PM CDT
Shares of Markel Corp. (MKL) scaled a new 52-week high of $669.68 on Oct 21.
AFSI: 50.47 (-1.02), HCI: 48.89 (-0.62), ENH: 57.74 (+0.21), MKL: 697.04 (+7.99)

Markel Corporation (MKL) Is Today's Strong And Under The Radar Stock
at The Street - Mon Oct 20, 10:32AM CDT
Trade-Ideas LLC identified Markel Corporation (MKL) as a strong and under the radar candidate
MKL: 697.04 (+7.99)

3 Smart Ways to Get Through a Market Crash
Motley Fool Staff - Motley Fool - Wed Oct 15, 7:45AM CDT
Source: Flickr user Universiteitskrant Univers. The stock market has been a rumbling, bumbling, stumbling mess over the past week and a half, and it's had plenty of traders on edge wondering whether or not they should cash in their chips and run...
KO: 42.29 (-0.02), JNJ: 109.01 (+0.19), V: 250.09 (+0.56), COF: 82.08 (+0.48), MKL: 697.04 (+7.99)

Today's Strong And Under The Radar Stock Is Markel Corporation (MKL)
at The Street - Mon Oct 13, 8:50AM CDT
Trade-Ideas LLC identified Markel Corporation (MKL) as a strong and under the radar candidate
MKL: 697.04 (+7.99)

Markel announces executive appointments in North America/Bermuda Claims
PR Newswire - Mon Oct 06, 2:40PM CDT
Markel Corporation (NYSE:MKL) announced today that the two senior claims executives in North America/Bermuda Claims are being promoted.
MKL: 697.04 (+7.99)

Markel Re announces leadership changes
PR Newswire - Tue Sep 30, 3:23PM CDT
Markel Corporation (NYSE: MKL) announced today that David Kalainoff, President and Chief Underwriting Officer -- Casualty of Markel's Global Reinsurance (Markel Re) division, is retiring effective June 1, 2015. Jed Rhoads, presently Markel Re's President and Chief Underwriting Officer -- Property, will assume responsibility for leading the division in June 2015. Both were previously employed by Alterra Capital Holdings, which was acquired by Markel in May 2013.
MKL: 697.04 (+7.99)

VizualNOW Hosts TV, Film, Web, Music, Gaming & Mobile Video Creator & Audience Builder Gathering September 14th
PRWeb - Thu Sep 18, 12:28AM CDT
VizualNOW co-founders Robin Berg and Gregory Markel hosted the most recent video creator and audience builder gathering in Santa Monica, CA this past Sunday, September 14th.
MKL: 697.04 (+7.99)

4 Years Invested: A Retrospective, Results, and Learnings
Michael Olsen, CFA, The Motley Fool - Motley Fool - Fri Sep 12, 8:38AM CDT
Scottish novelist Walter Scott once mused: What is a diary as a rule? A document useful to the person who keeps it. Dull to the contemporary who reads it and invaluable to the student, centuries afterwards, who treasures it. To publicly...
RKT: 54.87 (+0.73), ABG: 72.82 (+1.93), IP: 52.47 (+0.09), XEC: 114.80 (+3.31), MCD: 94.66 (+0.02), LOCO: 37.30 (+0.95), WTW: 25.32 (+0.07), ICLR: 52.27 (+0.38), WLP: 127.80 (+0.77), SIRI: 3.45 (-0.04), GWR: 97.03 (+1.76), MKL: 697.04 (+7.99)

Markel Global Reinsurance adds Erik Manning, Jamie Welsby and John Duda to its team
PR Newswire Europe - Thu Sep 11, 1:52PM CDT
Markel Corporation announced today that Dr. Erik Manning and Jamie Welsby have been appointed Managing Directors of Markel Global Reinsurance (Markel Re), Markel Corporation's reinsurance operating division. In addition, John Duda has been appointed Assistant Vice President, Reinsurance Underwriter for Markel Re.
MKL: 697.04 (+7.99)

4 Reasons Investors Should Love This Mini-Berkshire's "Boring" Acquisitions
Steve Symington, The Motley Fool - Motley Fool - Sat Sep 06, 7:05AM CDT
Markel recently added industrial waffle lines to its repertoire. Credit: Vanderpol. Heads up, Markel   investors, because your favorite mini- Berkshire Hathaway just added "waffle maker" to its resume. Specifically, through its Markel Ventures...
MKL: 697.04 (+7.99)

Markel (MKL) Down to Strong Sell on Rising Financial Risks - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 5:17PM CDT
On Aug 30, 2014, Zacks Investment Research downgraded Markel Corp. (MKL) by two notches to a Zacks Rank #5 (Strong Sell).
MCY: 54.75 (-0.22), ENH: 57.74 (+0.21), GBLI: 28.96 (+0.16), MKL: 697.04 (+7.99)

Markel Buys Vanderpol & Den Boer, Grows in Bakery Sector - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 02, 4:45PM CDT
Markel Ventures Inc., a subsidiary of Markel Corporation (MKL) announced the buyout of Vanderpol and Den Boer, thereby expanding in the specialty bakery sector.
AFSI: 50.47 (-1.02), ENH: 57.74 (+0.21), GBLI: 28.96 (+0.16), MKL: 697.04 (+7.99)

Markel Ventures Announces Acquisition Of Vanderpol & Den Boer
PR Newswire - Fri Aug 29, 3:30PM CDT
Markel Ventures, Inc. announced today that its subsidiary, AMF/Tromp B.V., has completed the acquisition of Tromp-Pol Baking Equipment B.V. ("Vanderpol" and Den Boer Baking Systems B.V. ("Den Boer" . Vanderpol and Den Boer design and manufacture waffle equipment, handling equipment, and ovens for bakers worldwide. Both companies are headquartered in the Netherlands.
MKL: 697.04 (+7.99)

Infuse Creative's Gregory Markel Appears on Ken Rutkowski's 'Business Rockstars' Show to Mentor WhereW/Who App Founder Max Siskin
PRWeb - Fri Aug 29, 3:21PM CDT
Founder and CEO of Infuse Creative, LLC, Gregory Markel, appeared as a mentor this past Tuesday on Ken Rutkowski's "Business Rockstars" radio and web show to join host Rutkowski in providing feedback and advice to 'WhereW/Who' App founder Max Siskin.
MKL: 697.04 (+7.99)

Markel Corp. (MKL) Stock Research Links

MKL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 129

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 0

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Vor Bio's Exploration of Strategic Alternatives for Growth

Updated Category News Views 213

Vor Bio Announces Exploration of Strategic Alternatives Today, Vor Bio, a clinical-stage cell and genome engineering company, has taken significant steps to enhance shareholder value. The decision comes at a time when the clinical data from its major programs suggests that reevaluating its approach could be beneficial in the face of challenging fundraising conditions....

Continue Reading
Kraig Biocraft Achieves Record Production in Spider Silk Fibers

Updated Category News Views 56

Kraig Biocraft Laboratories' Milestone in Spider Silk Production Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), a pioneering firm renowned for its innovative developments in spider silk-based fibers, is thrilled to share the successful conclusion of its fourth production cycle for the year. This cycle represents a remarkable achievement, showcasing record-breaking...

Continue Reading
Gen X Faces Retirement Challenges: Understanding the Crisis

Updated Category News Views 282

Gen X’s Coming Retirement Crunch Gen X—often called the “sandwich generation”—is being pulled in two directions at once and edging toward a retirement problem many don’t fully see. With money, time, and attention split between family and work, long-term savings can drift to the back burner. The worry isn’t abstract; it’s about whether the money will be...

Continue Reading
Luxurious Villa Spectre: A $55 Million Icon of Elegance

Updated Category News Views 342

Villa Spectre: A $55 Million Marvel of Luxury Living Villa Spectre has recently captured the spotlight as the highest-priced sale in the area, setting a remarkable benchmark in luxury real estate. This impressive estate was sold for $55,000,000, showcasing the allure and opulence that the elite have come to expect from high-end properties. A Visionary Creation Designed by...

Continue Reading
Mosaic Minerals Shifts Focus to Gold with Amanda Acquisition

Updated Category News Views 333

Mosaic Minerals Re-prioritizes Focus on Gold Exploration Mosaic Minerals Corporation (CSE: MOC) is making a strategic pivot in its exploration efforts. The company has announced the cessation of its lithium exploration initiatives, particularly those in Jamésie, Quebec. Instead, Mosaic is setting its sights on more promising ventures in gold and nickel, specifically...

Continue Reading